P

Assignee

ZYMA SA

CH17 patents

Top patents by PatentIndex Score

US4728513AMar 1, 1988

Granular delayed-release form of pharmaceutically active substances

ZYMA SA159 citations96
US4882169ANov 21, 1989

Swellable pellets

ZYMA SA57 citations94
US4784858ANov 15, 1988

Controlled release tablet

ZYMA SA117 citations94
US4814346AMar 21, 1989

Benzopyrans and use thereof in treating vascular diseases

ZYMA SA132 citations90
US4797414AJan 10, 1989

Naphthothiophene derivatives and their use as respiratory enhancing agents

ZYMA SA25 citations89
US4515804AMay 7, 1985

Crystal modifications of (+)-catechin and pharmaceutical preparations containing them

ZYMA SA29 citations87
US4644011AFeb 17, 1987

Pharmaceutical preparations containing (+)-cyanidan-3-ol derivatives, the use thereof, novel substituted (+)-cyanidan-3-ol derivatives, and processes for producing them

ZYMA SA18 citations69
US4153788AMay 8, 1979

Process of preparing mono-O-β-hydroxyethyl-7 rutoside

ZYMA SA12 citations69
US4665202AMay 12, 1987

Flavene and thioflavene derivatives

ZYMA SA12 citations68
US5212187AMay 18, 1993

Pyridyl alkylamine compounds which are useful against histamine h1 and h2 receptors

ZYMA SA13 citations65
US4904675AFeb 27, 1990

Phamacologically active 5-carboxy-2-(5-tetrazolyl) pyridines

ZYMA SA11 citations64
US4885298ADec 5, 1989

Pharmaceutical preparations containing flavanone or thioflavanone derivatives the use thereof, novel flavanones and thioflavanones, and processes for their manufacture

ZYMA SA4 citations59
US4342745AAug 3, 1982

Use of polyvinyl alcohols for the treatment of lesions

ZYMA SA10 citations59
US4510159AApr 9, 1985

(+)-Cyanidan-3-ol derivatives, pharmaceutical preparations that contain such compounds, and the use of the latter to treat liver or venous diseases

ZYMA SA2 citations57
US4946861AAug 7, 1990

1,3-dithian-2-ylidenes, their oxides, pharmaceutical compositions, and methods of use thereof

ZYMA SA5 citations52
US4935441AJun 19, 1990

Flavene and thioflavene derivates, processes for their manufacture, pharmaceutical preparations that contain such compounds, and the use of the latter

ZYMA SA1 citations48
US4634718AJan 6, 1987

Use of O-substituted derivatives of (+)-cyanidan-3-ol as compounds having immunomodulating properties

ZYMA SA1 citations47